In the treatment of osteoporosis, biologic and biosimiar medications may be provided as part of a treatment plan. What do healthcare providers need to know?
Join Dr. Alan Low as he shares information on Biologics & Biosimilars – An Overview for Healthcare Providers on September 5th. Information presented will include how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.
Webinar Details
Date: September 5, 2024
Time:
12:00 pm – 1:00 pm PT
1:00 pm – 2:00 pm MT
2:00 pm – 3:00 pm CT
3:00 pm – 4:00 pm ET
4:00 pm – 5:00 pm AT
4:30 pm – 5:30 pm NT
PRESENTER
Dr. Alan Low is a Clinical Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, Care Director at MedInfuse Health, and Primary Care Pharmacist / Pharmacy Lead at BioPro Biologics Pharmacy.
He is a member of Osteoporosis Canada’s Scientific Advisory Council, Board Advisor with the GI Society and a member of the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare and clinical projects as well as health advocacy. Together with a nurse educator and rheumatologist, Dr. Low has coauthored “The Osteoporosis Book, 4th Edition: Bone Health”.
In addition, he has been the Co-Editor of the Health Matters Bulletin, published articles in scientific and health journals and newsletters, and is a founding Co-Editor of the Pharmacy Management in Canada textbook.